Bugworks Research, Inc is a clinical stage biopharmaceutical company based in Fremont, CA. They are dedicated to developing affordable and accessible therapies for infectious diseases and cancer, utilizing the power of science. With a focus on antibacterial agents and immuno-oncology, their research programs aim to provide innovative solutions to address the global disease burden caused by antimicrobial resistance and cancers.
Bugworks' pipeline consists of targeted small molecules for the treatment of multidrug-resistant microbial infections and hypoxic, immunosuppressed, refractory solid tumors. Their team of highly experienced scientists, with a combined experience of over 200 years in Drug Discovery, collaborates with globally reputed partners to propel their breakthrough broad-spectrum assets. Through their cutting-edge technologies, Bugworks aims to combat serious hospital and community infections, as well as a broad spectrum of biothreat pathogens.
Generated from the website